Lobbying

Vaxxinity's latest lobbying report covers Q4 2022, at $50K. Its first report covers Q4 2022; the issues it reports most are Aerospace and Defense.

Vaxxinity

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Vaxxinity lobbying by quarter
Vaxxinity lobbying by quarter
QuarterAmountReports
Q4 2022$50K1
Q1 2023$00
Q2 2023$00
Q3 2023$00
Q4 2023$00
Q1 2024$00
Q2 2024$00
Q3 2024$00
Q4 2024$00
Q1 2025$00
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Aerospace$8,333 · 1 reports
  • Defense$8,333 · 1 reports
  • Health issues$8,333 · 1 reports
  • Manufacturing$8,333 · 1 reports
  • Medical research and clinical labs$8,333 · 1 reports
  • Veterans$8,333 · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Commerce, Dept of (DOC)1 reports
  • Defense, Dept of (DOD)1 reports
  • Health & Human Services, Dept of (HHS)1 reports
  • HOUSE OF REPRESENTATIVES1 reports
  • Natl Aeronautics & Space Administration (NASA)1 reports
  • Natl Institutes of Health (NIH)1 reports
  • SENATE1 reports
  • Veterans Affairs, Dept of (VA)1 reports

Firms it paid

Firm
Buchanan Ingersoll & Rooney PC$50K1 quarters

Former officials lobbying for it

Former position
EMILY ELAINE COYLELegislative Director, Rep. Debbie Wasserman SchultzQ4 2022

Lobbying reports

Filed by
23/01/20for Q4 2022Buchanan Ingersoll & Rooney PC$50K